IHH Healthcare’s net income doubles net income to $152.1m in 3Q23

The company attributed the higher net income to higher patient volumes and improved case mix.

SGX-listed IHH Healthcare more than doubled its net income in 3Q23, earning RM532.1m ($152.1m).

The company attributed its higher net income to higher patient volumes and improved case mix.

In the same period, IHH Healthcare's revenue and earnings before interest, taxes, depreciation, and amortisation (EBITDA) grew double digits.

In 3Q23, the company’s revenue rose 27% YoY to RM5.8b ($1.7b), whilst its EBITDA jumped 42% YoY to RM1.4b ($400m).

Following its stellar performance in 3Q23, the company paid its shareholders an Interim cash dividend of 3.5 sen ($0.010) per ordinary share on 27 October.

1 SGD = 3.50 RM

Follow the link for more news on

IHH Healthcare

Financial Statements

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia